---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-091482"
form_type: "8-K"
ticker: "SGHT"
cik: "0001531177"
company_name: "Sight Sciences, Inc."
filed_at: "2026-03-04T23:59:59+00:00"
generated_at: "2026-05-15T21:40:41.967233+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sight Sciences Q4 revenue $20.4M (+7% YoY); guides 2026 revenue $82-88M

## Summary
- Q4 2025 revenue $20.4M (+7% YoY); Interventional Glaucoma $19.7M (+5% YoY); Dry Eye $0.7M vs $0.3M.
- Q4 net loss $4.2M ($0.08 loss per share) vs $11.8M loss in Q4 2024; full-year net loss $38.4M vs $51.5M.
- Cash $92M at Dec 31, 2025; Q4 cash used only $0.4M; full-year cash used $28.4M.
- FY 2026 guidance: revenue $82-88M (+6-14% YoY); Glaucoma $77-81M; Dry Eye $5-7M.
- Operating expenses down 25% Q4 and 13% full-year; adjusted op ex guidance $93-96M for 2026.

## SEC filing metadata
- accession: 0001193125-26-091482
- form_type: 8-K
- ticker: SGHT
- cik: 0001531177
- company_name: Sight Sciences, Inc.
- filed_at: 2026-03-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091482/0001193125-26-091482-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091482/sght-20260304.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-091482
- JSON: https://secwatch.observer/filing/0001193125-26-091482.json
- Plain text: https://secwatch.observer/filing/0001193125-26-091482.txt

## Key facts
- Earnings Releases
  Sight Sciences, Inc. reported the fourth quarter and full year ended December 31, 2025 results: revenue $20.4 million, net income $4.2 million, EPS $0.08 per share. Guidance initiated.
  - Period: the fourth quarter and full year ended December 31, 2025
  - Revenue: $20.4 million
  - Net income: $4.2 million
  - EPS: $0.08 per share
  - Guidance: initiated
  - Result: reported results
  source text: quarter and full year ended December 31, 2025 and initiated financial guidance for full year 2026. Recent Financial Highlights • Generated fourth quarter 2025 total revenue of $20.4 million, an increase of 7% compared to the same period in the prior year, and full year 2025 total revenue of $77.4 million, a decrease of 3% compared to full year 2024. • Achieved total
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091482/0001193125-26-091482-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.